Novateor Research Laboratories Ltd
BSE:542771
Cash Flow Statement
Cash Flow Statement
Novateor Research Laboratories Ltd
| Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(2)
|
(2)
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
(5)
|
(5)
|
(5)
|
(7)
|
(4)
|
|
| Cash Taxes Paid |
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Change in Working Capital |
(9)
|
(9)
|
(10)
|
(6)
|
(6)
|
(6)
|
(7)
|
(9)
|
|
| Cash from Operating Activities |
(10)
N/A
|
(10)
-1%
|
(8)
+20%
|
(10)
-25%
|
(10)
-1%
|
(10)
+0%
|
(12)
-27%
|
(10)
+17%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
0
|
0
|
(16)
|
(4)
|
0
|
(7)
|
(10)
|
(7)
|
|
| Other Items |
9
|
9
|
(9)
|
5
|
5
|
5
|
7
|
5
|
|
| Cash from Investing Activities |
9
N/A
|
9
+5%
|
(25)
N/A
|
1
N/A
|
2
+73%
|
(3)
N/A
|
(3)
-14%
|
(2)
+23%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
9
|
17
|
17
|
|
| Net Issuance of Debt |
2
|
0
|
2
|
6
|
7
|
3
|
(3)
|
(2)
|
|
| Other |
1
|
(2)
|
1
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
2
N/A
|
(1)
N/A
|
4
N/A
|
6
+56%
|
8
+30%
|
11
+45%
|
14
+26%
|
14
+3%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
1
N/A
|
(2)
N/A
|
(29)
-1 477%
|
(3)
+91%
|
0
N/A
|
(1)
N/A
|
(1)
-14%
|
2
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(10)
N/A
|
(10)
-1%
|
(24)
-143%
|
(13)
+44%
|
(10)
+26%
|
(17)
-75%
|
(22)
-30%
|
(17)
+22%
|
|